William Blair & Company’s Viking Therapeutics, Inc. VKTXW Stock Holding History

William Blair & Company’s Portfolio VKTXW Stock Details VKTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-7,200	Closed	-$39K	–	1826
2019 Q3	$39K	Sell	7,200 -1,870	-21%	-$11K	﹤0.01%	1483
2019 Q2	$61K	Sell	9,070 -41,910	-82%	-$300K	﹤0.01%	1477
2019 Q1	$427K	Sell	50,980 -10,525	-17%	-$71.9K	﹤0.01%	1012
2018 Q4	$375K	Sell	61,505 -49,300	-44%	-$517K	﹤0.01%	1005
2018 Q3	$1.77M	Sell	110,805 -15,740	-12%	-$164K	0.01%	583
2018 Q2	$1.02M	Buy	126,545 +101,025	+396%	+$529K	0.01%	716
2018 Q1	$77K	Buy	+25,520	New	+$104K	﹤0.01%	1299

Other funds holding VKTXW

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

William Blair & Company's VKTXW Position: Q4 2019 in Review

William Blair & Company sold out of Viking Therapeutics, Inc. (VKTXW) in Q4 2019, closing a stake of 7,200 shares — an estimated $39K sold.

William Blair & Company first reported a position in VKTXW in Q1 2018 and held it in 7 quarters. The position peaked at $1.77M in Q3 2018. 3 funds tracked by Wall St. Rank hold VKTXW as of Q4 2019.

William Blair & Company reported no remaining Viking Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
William Blair & Company sold 7,200 Viking Therapeutics, Inc. shares in Q4 2019, an estimated $39K.
William Blair & Company first reported a position in Viking Therapeutics, Inc. in Q1 2018 and held it in 7 quarters.
William Blair & Company's Viking Therapeutics, Inc. position peaked at $1.77M in Q3 2018.
3 funds tracked by Wall St. Rank held Viking Therapeutics, Inc. as of Q4 2019.

Based on William Blair & Company's 13F filing for Q4 2019, filed 13 Feb 2020.